Up next

Autoplay

Considerations for CPX-351 in Acute Myeloid Leukemia

2 Views • 07/04/23
Share
Embed
administrator
administrator
Subscribers
0

Expert panelists Eunice Wang, MD; Harry Erba, MD, PhD; Alexander E. Perl, MD; and Jorge E. Cortes, MD, identify important considerations when treating acute myeloid leukemia with CPX-351, such as its toxicity profile and patient stratification.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay